Research articlePublished 25 Jan 2019
Relationship of body mass index with diabetes and breast cancer biomarkers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Body mass index (BMI=Weight(kg)/Height(m2) is generally computed for each patient under some clinical studies, considering that it may be related with the disease. The report has derived the effects of BMI on diabetes & breast cancer markers for some cancer patients with the help of probabilistic modeling. It has been obtained that mean BMI is positively associated with fasting glucose (p=0.0753), insulin (p=0.0002), leptin (p<0.0001), monocyte chemoattractant protein-1 (MCP-1) (p=0.0002), and it is negatively associated with homeostasis model assessment score (HOMA) (p<0.0001), adiponectin (p=0.0003), and class of patients (p=0.0116). The variance of BMI is partially positively associated with age (p=0.1751), and it is negatively associated with resistin (p=0.1450) and insulin (p=0.2413). These three variance explanatory factors are known as confounder according to Epidemiology. Therefore, high BMI increases glucose, insulin, leptin, MCP-1, and it decreases HOMA & adiponectin.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDiabetes Management
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Rabindra Nath Das”
- BylineArticles whose byline prints “Youngjo Lee”
- BylineArticles whose byline prints “Sabyasachi Mukherjee & Seungyoung Oh”